Public trial
RBR-6p8pkvq Diagnostic exam for renal cancer
Date of registration: 07/26/2023 (mm/dd/yyyy)Last approval date : 07/26/2023 (mm/dd/yyyy)
Study type:
Observational
Scientific title:
en
Prospective evaluation of the use of PET/CT with 18 F-PSMA in kidney cancer
pt-br
Avaliação prospectiva do uso do PET/CT com 18F-PSMA no câncer renal
es
Prospective evaluation of the use of PET/CT with 18 F-PSMA in kidney cancer
Trial identification
- UTN code: U1111-1294-2125
-
Public title:
en
Diagnostic exam for renal cancer
pt-br
Exame para diagnóstico de câncer renal
-
Scientific acronym:
-
Public acronym:
-
Secondaries identifiers:
-
49680621.2.0000.5432
Issuing authority: Plataforma Brasil
-
5.035.725
Issuing authority: Comitê de Ética em Pesquisa do AC Camargo Cancer Center
-
49680621.2.0000.5432
Sponsors
- Primary sponsor: Fundação Antônio Prudente - AC Camargo Cancer Center
-
Secondary sponsor:
- Institution: Fundação Antônio Prudente - AC Camargo Cancer Center
-
Supporting source:
- Institution: Fundação Antônio Prudente - AC Camargo Cancer Center
Health conditions
-
Health conditions:
en
Renal Cancer
pt-br
Câncer Renal
-
General descriptors for health conditions:
en
E01.370.350 Diagnostic Imaging
pt-br
E01.370.350 Diagnóstico por Imagem
-
Specific descriptors:
en
C04.588.945.947.535 Renal cancer
pt-br
C04.588.945.947.535 Câncer renal
Interventions
-
Interventions:
en
Observational, unicentric study, with prospective data collection, which will be developed in the Nuclear Medicine and Urology Departments of the ACCamargo Cancer Center. A total of 30 patients with histopathological diagnosis of renal cancer, clear cell or papillary subtypes, will be prospectively included and analyzed with the PET/CT study with 18 F-PSMA
pt-br
Estudo observacional, unicêntrico, com coleta prospectiva de dados, que será desenvolvido nos Departamentos de Medicina Nuclear e Urologia do A.C.CamargoCancer Center. Um total de 30 pacientes com diagnóstico histopatológico de câncer renal, dos subtipos células claras ou papilífero, serão prospectivamente incluídos e analisados com o estudo de PET/CT com 18F-PSMA
-
Descriptors:
en
V03.175.500 Observational Study
pt-br
V03.175.500 Estudo Observacional
Recruitment
- Study status: Recruiting
-
Countries
- Brazil
- Date first enrollment: 01/01/2023 (mm/dd/yyyy)
-
Target sample size: Gender: Minimum age: Maximum age: 30 - 18 Y 0 -
Inclusion criteria:
en
Patients aged at least 18 years; both genders; with histopathological diagnosis of renal cancer, clear cell or papillary subtypes
pt-br
Pacientes com idade mínima de 18 anos; ambos os gêneros; com diagnóstico histopatológico de Câncer renal, dos subtipos células claras ou papilífero
-
Exclusion criteria:
en
None
pt-br
Nenhum
Study type
-
Study design:
-
Expanded access program Purpose Intervention assignment Number of arms Masking type Allocation Study phase
Outcomes
-
Primary outcomes:
en
To evaluate the diagnostic capability of 18F-PSMA PET/CT in patients with renal cancer compared to conventional exams and 18F-FDG PET/CT based on the use of standardized uptake value (SUV)
pt-br
Avaliar a capacidade diagnóstica do PET/CT com 18F-PSMA em pacientes com câncer renal em comparação aos exames convencionais e ao PET/CT com 18F-FDG baseado na utilização do SUV (standardized uptake value)
-
Secondary outcomes:
en
No secondary outcomes are expected
pt-br
Não são esperados desfechos secundários
Contacts
-
Public contact
- Full name: Eduardo Nóbrega Pereira Lima
-
- Address: R. Prof. Antônio Prudente, 211, Liberdade
- City: São Paulo / Brazil
- Zip code: 01509-900
- Phone: +55(11)21895000, Ramal 2832
- Email: eduardo.lima@accamargo.org.br
- Affiliation: AC Camargo Cancer Center
-
Scientific contact
- Full name: Andre Marcondes Braga Ribeiro
-
- Address: Rua Professor Antônio Prudente, 266
- City: São Paulo / Brazil
- Zip code: 01509-900
- Phone: +55(11)21895000 - Ramal 2832
- Email: andre.ribeiro@accamargo.org.br
- Affiliation: AC Camargo Cancer Center
-
Site contact
- Full name: Juliana Oliveira Souza
-
- Address: Rua Professor Antônio Prudente 211
- City: Sao Paulo / Brazil
- Zip code: 01509-900
- Phone: +55(11)21895000 - Ramal 2832
- Email: juliana.oliveira@accamargo.org.br
- Affiliation: AC Camargo Cancer Center
Additional links:
Total de Ensaios Clínicos 16961.
Existem 8355 ensaios clínicos registrados.
Existem 4701 ensaios clínicos recrutando.
Existem 236 ensaios clínicos em análise.
Existem 5772 ensaios clínicos em rascunho.